| Authors: |
Donaldson A; Viral Immunology Section, National Institute of Neurological Disorders and Stroke (NINDS) and., Druker MR; Viral Immunology Section, National Institute of Neurological Disorders and Stroke (NINDS) and., Monaco MC; Viral Immunology Section, National Institute of Neurological Disorders and Stroke (NINDS) and., Stack EH; Viral Immunology Section, National Institute of Neurological Disorders and Stroke (NINDS) and., Zimmerman P; Viral Immunology Section, National Institute of Neurological Disorders and Stroke (NINDS) and., Lee A; Translational Neuroradiology Section, NINDS, NIH, Bethesda, Maryland, USA., Bialuk I; Department of General and Experimental Pathology, Medical University of Białystok, Białystok, Poland., Frazier W; Viral Immunology Section, National Institute of Neurological Disorders and Stroke (NINDS) and., Cortese I; Experimental Immunotherapeutics Unit and., Narver H; Animal Health and Care Section, NINDS, NIH, Bethesda, Maryland, USA., Hazama M; SymBio Pharmaceuticals Limited, Tokyo, Japan., Yoshida F; SymBio Pharmaceuticals Limited, Tokyo, Japan., Li X; HIV and AIDS Malignancy Branch, National Cancer Institute, NIH, Bethesda, Maryland, USA., Krug LT; HIV and AIDS Malignancy Branch, National Cancer Institute, NIH, Bethesda, Maryland, USA., Piotrowski SL; Viral Immunology Section, National Institute of Neurological Disorders and Stroke (NINDS) and., Jacobson S; Viral Immunology Section, National Institute of Neurological Disorders and Stroke (NINDS) and. |
